BioXcel's (BTAI) OnkosXcel Therapeutics Files for Proposed IPO

Go back to BioXcel's (BTAI) OnkosXcel Therapeutics Files for Proposed IPO

OnkosXcel Therapeutics Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering

March 14, 2023 4:15 PM UTC

NEW HAVEN, Conn., March 14, 2023 (GLOBE NEWSWIRE) -- OnkosXcel Therapeutics, LLC (OnkosXcel) today announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the SEC) relating to the proposed initial public offering of its common stock following its conversion into a corporation. The... More